Metaprodigiosin production strain and separation and purification process thereof
By using the specific high-yield strain Streptomyces citrus YS-4 and its combination for separation and purification, the problems of low yield and low purity in the production of meclofenoxuron were solved, achieving efficient and high-purity preparation of meclofenoxuron, which is suitable for the development of drugs against drug-resistant bacteria.
Patent Information
- Application Number
- CN202610229776.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-02-26
- Publication Date
- 2026-06-02
AI Technical Summary
Existing technologies for producing erythromycin from intermediate-loop cyclophosphamide strains exhibit poor metabolic specificity, low extraction yield, and difficulty in separation and purification, making it challenging to obtain high-purity products.
The specific high-yielding strain *Streptomyces citrus* YS-4 was used, combined with a combined technical route of fermentation regulation, biphasic extraction, polarity screening and hydrophobic purification. This included ethyl acetate extraction of the fermentation supernatant, methanol extraction of the bacterial cells, normal-phase silica gel chromatography and Sephadex LH-20 gel column chromatography, and finally purification by C18 reversed high-performance liquid chromatography.
The method achieves high-abundance extraction and high-purity separation of cyclophosphamide erythrin, with a product yield superior to that of the single solvent method, a product purity of 98.6%, and maintains biological activity, making it suitable for the development of drugs against drug-resistant bacteria.